Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia

Coronavirus disease (COVID-19) in Colombia was first diagnosed in a traveler arriving from Italy on February 26, 2020. However, limited data are available on the origins and number of introductions of COVID-19 into the country. We sequenced the causative agent of COVID-19, severe acute respiratory s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Emerging infectious diseases 2020-12, Vol.26 (12), p.2854-2862
Hauptverfasser: Laiton-Donato, Katherine, Villabona-Arenas, Christian Julián, Usme-Ciro, José A, Franco-Muñoz, Carlos, Álvarez-Díaz, Diego A, Villabona-Arenas, Liz Stephany, Echeverría-Londoño, Susy, Cucunubá, Zulma M, Franco-Sierra, Nicolás D, Flórez, Astrid C, Ferro, Carolina, Ajami, Nadim J, Walteros, Diana Marcela, Prieto, Franklin, Durán, Carlos Andrés, Ospina-Martínez, Martha Lucia, Mercado-Reyes, Marcela
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Coronavirus disease (COVID-19) in Colombia was first diagnosed in a traveler arriving from Italy on February 26, 2020. However, limited data are available on the origins and number of introductions of COVID-19 into the country. We sequenced the causative agent of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from 43 clinical samples we collected, along with another 79 genome sequences available from Colombia. We investigated the emergence and importation routes for SARS-CoV-2 into Colombia by using epidemiologic, historical air travel, and phylogenetic observations. Our study provides evidence of multiple introductions, mostly from Europe, and documents >12 lineages. Phylogenetic findings validate the lineage diversity, support multiple importation events, and demonstrate the evolutionary relationship of epidemiologically linked transmission chains. Our results reconstruct the early evolutionary history of SARS-CoV-2 in Colombia and highlight the advantages of genome sequencing to complement COVID-19 outbreak investigations.
ISSN:1080-6040
1080-6059
DOI:10.3201/eid2612.202969